Neostem (NBS) Posts Q3 Loss of 6c/Share

Neostem (AMEX: NBS) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on Neostem (NBS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)